The size of the Blood Pressure Monitoring Device Market in MEA was worth USD 254.43 Million in 2020 and estimated to be growing at a CAGR of 8.11%, to reach USD 375.77 Million by 2025.
Hypertension is a chronic condition but can be managed with medication and a better lifestyle. Many people are focusing on reducing their medical expenses and hospital stays, with emphasis on quality care and disease management. Be it due to the sedentary lifestyle, lack of physical activity, or rising stress level, even younger people are also complaining of blood pressure and hypertension. The reason being, an unhealthy diet and changing lifestyle.
The Middle East and Africa Blood Pressure Monitoring Devices Market is an emerging market for blood pressure monitoring devices. Factors such as a sedentary lifestyle leading to high chronic disease burden and easy access to diagnostic technologies and health care professionals are driving the blood pressure monitoring devices market in the region.
In the Middle East and Africa Digital sphygmomanometer segment is expected to witness lucrative growth in the coming years owing to advantages associated with these devices such as ease of use, accurate results, and low cost. Blood pressure monitoring devices market is majorly driven by the rising prevalence of heart disorders. Advanced handheld and automated blood pressure monitors offer features such as safety, efficacy, and portability, thereby boosting the market growth. The increasing popularity of the mHealth platform in the healthcare sector is additionally, propelling the market growth. The handling of these devices needs accuracy which is a major drawback.
This research report segmented and sub-segmented into the following categories:
Leading companies in the MEA Blood Pressure Monitoring Device Market profiled in this report are GE Healthcare, Welch Allyn, A&D Medical Inc., SunTech Medical, Rossmax International Ltd, Spacelabs Healthcare Inc. Panasonic Corporation, Philips Healthcare, Contec Medical Systems Co. Ltd, Omron Healthcare and Microlife AG.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Type
5.1.1 Automated BP Monitors
5.1.2 Ambulatory BP Monitors
5.1.3 Sphygmomanometers
5.1.3.1 Mercury
5.1.3.2 Aneroid
5.1.3.3 Digital
5.1.4 BP Transducers
5.1.5 BP instruments accessories
6. Geographical Analysis
6.1 Introduction
6.2 Middle-East
6.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Welch Allyn
8.3 A&D Medical Inc
8.4 SunTech Medical
8.5 Rossmax International Ltd
8.6 Spacelabs Healthcare Inc
8.7 Panasonic Corporation
8.8 Philips Healthcare
8.9 Contec Medical Systems Co. Ltd
8.10 Omron Healthcare
8.11 Microlife AG
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
